BACKGROUND: Epidemiologic studies of the association of folate intake with breast cancer risk have been inconclusive, and few have investigated how related nutrients modify this association. OBJECTIVE: We investigated the association of dietary (food folate plus folic acid from fortification) and total folate (food folate, folic acid from fortification, and folic acid from supplements), vitamin B-6, vitamin B-12, methionine, and alcohol intakes with postmenopausal breast cancer among women in the Cancer Prevention Study II Nutrition Cohort. The modification of the folate associations by the other nutrients was also investigated. DESIGN: This prospective cohort study included 70,656 postmenopausal women for whom dietary information was collected in 1992. Of these, 3898 developed breast cancer between enrollment in 1992 and June 2005. Cox proportional hazards modeling was used to calculate multivariate-adjusted hazard rate ratios and 95% CIs. RESULTS: Compared with the lowest quintile, the highest quintile of dietary folate intake was associated with a higher risk of breast cancer (rate ratio: 1.12; 95% CI: 1.01, 1.24). However, the test for trend was not significant (P for trend = 0.15). No association was found for total folate, vitamin B-6, or vitamin B-12, but methionine was inversely associated with breast cancer risk (P for trend = 0.04). The association of dietary folate with breast cancer was not modified by other nutrients or alcohol. CONCLUSIONS: This study suggests that dietary folate intake may be positively associated with postmenopausal breast cancer. However, no dose-response relation was observed. The extent to which increased supplement use and folate fortification contributes to breast cancer risk warrants further research.
BACKGROUND: Epidemiologic studies of the association of folate intake with breast cancer risk have been inconclusive, and few have investigated how related nutrients modify this association. OBJECTIVE: We investigated the association of dietary (food folate plus folic acid from fortification) and total folate (food folate, folic acid from fortification, and folic acid from supplements), vitamin B-6, vitamin B-12, methionine, and alcohol intakes with postmenopausal breast cancer among women in the Cancer Prevention Study II Nutrition Cohort. The modification of the folate associations by the other nutrients was also investigated. DESIGN: This prospective cohort study included 70,656 postmenopausal women for whom dietary information was collected in 1992. Of these, 3898 developed breast cancer between enrollment in 1992 and June 2005. Cox proportional hazards modeling was used to calculate multivariate-adjusted hazard rate ratios and 95% CIs. RESULTS: Compared with the lowest quintile, the highest quintile of dietary folate intake was associated with a higher risk of breast cancer (rate ratio: 1.12; 95% CI: 1.01, 1.24). However, the test for trend was not significant (P for trend = 0.15). No association was found for total folate, vitamin B-6, or vitamin B-12, but methionine was inversely associated with breast cancer risk (P for trend = 0.04). The association of dietary folate with breast cancer was not modified by other nutrients or alcohol. CONCLUSIONS: This study suggests that dietary folate intake may be positively associated with postmenopausal breast cancer. However, no dose-response relation was observed. The extent to which increased supplement use and folate fortification contributes to breast cancer risk warrants further research.
Authors: Zhihong Gong; Christine B Ambrosone; Susan E McCann; Gary Zirpoli; Urmila Chandran; Chi-Chen Hong; Dana H Bovbjerg; Lina Jandorf; Gregory Ciupak; Karen Pawlish; Quanjun Lu; Helena Hwang; Thaer Khoury; Bshara Wiam; Elisa V Bandera Journal: Int J Cancer Date: 2013-09-30 Impact factor: 7.396
Authors: Galina Lurie; Lynne R Wilkens; Yurii B Shvetsov; Nicholas J Ollberding; Adrian A Franke; Brian E Henderson; Laurence N Kolonel; Marc T Goodman Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-08-09 Impact factor: 4.254
Authors: Yuan Ji; Kendra K S Nordgren; Yubo Chai; Scott J Hebbring; Gregory D Jenkins; Ryan P Abo; Yi Peng; Linda L Pelleymounter; Irene Moon; Bruce W Eckloff; Xiaoshan Chai; Jianping Zhang; Brooke L Fridley; Vivien C Yee; Eric D Wieben; Richard M Weinshilboum Journal: Drug Metab Dispos Date: 2012-07-17 Impact factor: 3.922
Authors: Ying Liu; Rulla M Tamimi; Catherine S Berkey; Walter C Willett; Laura C Collins; Stuart J Schnitt; James L Connolly; Graham A Colditz Journal: Pediatrics Date: 2012-04-09 Impact factor: 7.124
Authors: Seungyoun Jung; Molin Wang; Kristin Anderson; Laura Baglietto; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Louise Brinton; Julie E Buring; A Heather Eliassen; Roni Falk; Susan M Gapstur; Graham G Giles; Gary Goodman; Judith Hoffman-Bolton; Pamela L Horn-Ross; Manami Inoue; Laurence N Kolonel; Vittorio Krogh; Marie Lof; Paige Maas; Anthony B Miller; Marian L Neuhouser; Yikyung Park; Kim Robien; Thomas E Rohan; Stephanie Scarmo; Leo J Schouten; Sabina Sieri; Victoria L Stevens; Schoichiro Tsugane; Kala Visvanathan; Lynne R Wilkens; Alicja Wolk; Elisabete Weiderpass; Walter C Willett; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Xuehong Zhang; Regina G Ziegler; Stephanie A Smith-Warner Journal: Int J Epidemiol Date: 2015-08-28 Impact factor: 7.196
Authors: Song-Yi Park; Laurence N Kolonel; Unhee Lim; Kami K White; Brian E Henderson; Lynne R Wilkens Journal: Int J Cancer Date: 2013-10-09 Impact factor: 7.396
Authors: Dongyan Yang; Richard N Baumgartner; Martha L Slattery; Chenxi Wang; Anna R Giuliano; Maureen A Murtaugh; Betsy C Risendal; Tim Byers; Kathy B Baumgartner Journal: PLoS One Date: 2013-02-11 Impact factor: 3.240
Authors: Shaidah Deghan Manshadi; Lisa Ishiguro; Kyoung-Jin Sohn; Alan Medline; Richard Renlund; Ruth Croxford; Young-In Kim Journal: PLoS One Date: 2014-01-21 Impact factor: 3.240